Sinovac Biotech Ltd.
SVA · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$117 | $17 | -$371 |
| Dep. & Amort. | – | $61 | $84 | $79 |
| Deferred Tax | – | $108 | -$32 | -$67 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | $278 | $0 | $640 |
| Other Non-Cash | – | -$184 | $39 | -$930 |
| Operating Cash Flow | – | $146 | -$40 | $152 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$53 | -$93 | -$150 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$1,703 | -$6,653 | $3,423 |
| Inv. Sales/Matur. | – | $1,560 | $4,015 | -$5,563 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$195 | -$2,731 | -$2,290 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $1 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$293 | $217 | -$253 |
| Financing Cash Flow | – | -$293 | $217 | -$253 |
| Forex Effect | – | $0 | -$86 | -$189 |
| Net Chg. in Cash | – | -$371 | -$2,640 | -$2,581 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $1,647 | $4,286 | $6,867 |
| End Cash | – | $1,275 | $1,647 | $4,286 |
| Free Cash Flow | – | $93 | -$133 | $2 |